Thus, we identify: (1) USP14 overexpression as a potential druggable target to increase radiosensitivity in NSCLC, and (2) a previously unexplored connection between USP14 and HR, known to regulate tumor cell response to RT. Here, USP14 is linked to non-small cell lung carcinoma.